Pretreatment serum uric acid level is not a surrogate marker for the outcome offavipiravir treatment in COVID-19 patients

Authors

AHMET ÇAĞKAN İNKAYA
EMRE KARA
NURSEL ÇALIK BAŞARAN
TAHA KORAY ŞAHİN
OĞUZ ABDULLAH UYAROĞLU
ÖMRÜM UZUN
SERHAT ÜNAL

DOI

10.3906/sag-2102-84

First Page

2786

Last Page

2788

Recommended Citation

İNKAYA, AHMET ÇAĞKAN; KARA, EMRE; BAŞARAN, NURSEL ÇALIK; ŞAHİN, TAHA KORAY; UYAROĞLU, OĞUZ ABDULLAH; UZUN, ÖMRÜM; and ÜNAL, SERHAT (2021) "Pretreatment serum uric acid level is not a surrogate marker for the outcome offavipiravir treatment in COVID-19 patients," Turkish Journal of Medical Sciences: Vol. 51: No. 5, Article 68. https://doi.org/10.3906/sag-2102-84
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss5/68